Vyome Holdings, Inc (HIND) stock
HINDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.20−0.25 (-17.24%)
Close on Nov 20, 2026Market cap $8.42MP/E –Yield –
Vyome gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Vyome's gross profit for the twelve months ending Jun 30, 2026 was $68.42K, down 75.4% year over year. For fiscal 2025 it was $218.77K, up 12.2% from the year before. Over ten years it grew -17.7% a year on average. The highest annual figure on record is $8.35M in fiscal 2021.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $218.77K | +12.2% |
| FY2024 | Dec 31, 2024 | $194.97K | -96.5% |
| FY2023 | Dec 31, 2023 | $5.55M | -18.4% |
| FY2022 | Dec 31, 2022 | $6.80M | -18.5% |
| FY2021 | Dec 31, 2021 | $8.35M | +33.3% |
| FY2020 | Dec 31, 2020 | $6.26M | +1791.8% |
| FY2019 | Dec 31, 2019 | $331.00K | -91.0% |
| FY2018 | Dec 31, 2018 | $3.68M | -27.7% |
| FY2017 | Dec 31, 2017 | $5.09M | +770.7% |
| FY2016 | Dec 31, 2016 | $584.00K | -62.0% |
| FY2015 | Dec 31, 2015 | $1.54M | +145.0% |
| FY2014 | Dec 31, 2014 | $627.00K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $11.66K | -51.9% |
| Q1 FY2026 | Mar 31, 2026 | $16.65K | -89.2% |
| Q4 FY2025 | Dec 31, 2025 | $22.07K | -64.8% |
| Q3 FY2025 | Sep 30, 2025 | $18.05K | -51.3% |
| Q2 FY2025 | Jun 30, 2025 | $24.24K | -97.9% |
| Q1 FY2025 | Mar 31, 2025 | $154.42K | -86.7% |
| Q4 FY2024 | Dec 31, 2024 | $62.76K | -96.6% |
| Q3 FY2024 | Sep 30, 2024 | $37.09K | -97.1% |
| Q2 FY2024 | Jun 30, 2024 | $1.13M | -5.0% |
| Q1 FY2024 | Mar 31, 2024 | $1.17M | -4.8% |
| Q4 FY2023 | Dec 31, 2023 | $1.84M | +15.1% |
| Q3 FY2023 | Sep 30, 2023 | $1.29M | -38.7% |
| Q2 FY2023 | Jun 30, 2023 | $1.19M | -36.6% |
| Q1 FY2023 | Mar 31, 2023 | $1.22M | +0.5% |
| Q4 FY2022 | Dec 31, 2022 | $1.60M | -9.9% |
| Q3 FY2022 | Sep 30, 2022 | $2.10M | -1.6% |
| Q2 FY2022 | Jun 30, 2022 | $1.88M | -12.5% |
| Q1 FY2022 | Mar 31, 2022 | $1.22M | -46.7% |
| Q4 FY2021 | Dec 31, 2021 | $1.78M | +8.2% |
| Q3 FY2021 | Sep 30, 2021 | $2.14M | -6.4% |
| Q2 FY2021 | Jun 30, 2021 | $2.15M | +157.2% |
| Q1 FY2021 | Mar 31, 2021 | $2.28M | +855.6% |
| Q4 FY2020 | Dec 31, 2020 | $1.64M | +925.6% |
| Q3 FY2020 | Sep 30, 2020 | $2.28M | – |
| Q2 FY2020 | Jun 30, 2020 | $837.00K | – |
| Q1 FY2020 | Mar 31, 2020 | $239.00K | -56.0% |
| Q4 FY2019 | Dec 31, 2019 | $160.00K | -69.9% |
| Q3 FY2019 | Sep 30, 2019 | -$79.00K | -105.0% |
| Q2 FY2019 | Jun 30, 2019 | -$293.00K | -129.3% |
| Q1 FY2019 | Mar 31, 2019 | $543.00K | -5.9% |
| Q4 FY2018 | Dec 31, 2018 | $532.00K | -73.3% |
| Q3 FY2018 | Sep 30, 2018 | $1.57M | +6.5% |
| Q2 FY2018 | Jun 30, 2018 | $1.00M | +2.8% |
| Q1 FY2018 | Mar 31, 2018 | $577.00K | -11.1% |
| Q4 FY2017 | Dec 31, 2017 | $1.99M | – |
| Q3 FY2017 | Sep 30, 2017 | $1.47M | +1041.9% |
| Q2 FY2017 | Jun 30, 2017 | $973.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $649.00K | – |
| Q4 FY2016 | Dec 31, 2016 | -$99.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $129.00K | – |
See a number that looks wrong?